Japan&#x27s SoftBank posts quarterly financial gain immediately after four straight losses, pushed by Vision Fund gains

Japan&#x27s SoftBank posts quarterly financial gain immediately after four straight losses, pushed by Vision Fund gains


Masayoshi Son, CEO of SoftBank, has been weighing up different solutions for chipmaker Arm right after Nvidia walked absent from purchasing the firm.

Alessandro Di Ciommo | Nurphoto | Getty Photographs

SoftBank posted its initially quarterly profit immediately after 4 quarters of losses, smashing as a result of analyst estimates, pushed by huge gains at its flagship tech expense arm, the Eyesight Fund.

Here’s how SoftBank did in the December quarter against LSEG estimates:

  • Net profits: 1.77 trillion Japanese yen versus 1.8 trillion Japanese yen anticipated.
  • Net cash flow: 950 billion Japanese yen as opposed to 196.5 billion yen predicted.

SoftBank’s flagship tech financial investment arm experienced a rough time in the fiscal 12 months that ended in March last 12 months, posting a document loss of about $32 billion amid a slump in tech stock charges and the souring of some of the business’ bets in China.



Supply

Jet fuel bidding war breaks out as airlines confront ‘global stress test’ over shortages and cancellations
World

Jet fuel bidding war breaks out as airlines confront ‘global stress test’ over shortages and cancellations

Europe is urgently turning to alternative suppliers of jet fuel as imports from the Middle East remain knocked out — but the continent must “fight for every cargo” in what analysts have dubbed a “global stress test” for the airline industry. The loss of Middle Eastern jet fuel because of the Iran war is quickly […]

Read More
Treasury yields are little changed as investors await Fed decision
World

Treasury yields are little changed as investors await Fed decision

Federal Reserve Board Chairman Jerome Powell speaks during a news conference following the Federal Open Market Committee meeting, at the Federal Reserve in Washington, DC, on June 14, 2023. Mandel Ngan | AFP | Getty Images U.S. Treasury yields were little changed on Wednesday as investors awaited the outcome of what could be Jerome Powell’s […]

Read More
UK’s biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
World

UK’s biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies

AstraZeneca and GSK, the U.K.’s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday. Source

Read More
Powered by WordPress | WP Magazine by WP Mag Plus